LeMaitre Vascular, Inc. (NASDAQ:LMAT) Position Increased by Teacher Retirement System of Texas

Teacher Retirement System of Texas increased its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 31.8% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 101,851 shares of the medical instruments supplier's stock after purchasing an additional 24,586 shares during the period. Teacher Retirement System of Texas owned 0.45% of LeMaitre Vascular worth $9,385,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Smartleaf Asset Management LLC raised its holdings in shares of LeMaitre Vascular by 234.4% during the fourth quarter. Smartleaf Asset Management LLC now owns 418 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 293 shares during the period. CBIZ Investment Advisory Services LLC grew its position in shares of LeMaitre Vascular by 38.5% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier's stock valued at $39,000 after buying an additional 117 shares during the last quarter. KBC Group NV raised its stake in LeMaitre Vascular by 58.4% during the fourth quarter. KBC Group NV now owns 1,112 shares of the medical instruments supplier's stock worth $102,000 after acquiring an additional 410 shares during the period. Empowered Funds LLC acquired a new stake in LeMaitre Vascular during the fourth quarter worth about $150,000. Finally, SG Americas Securities LLC bought a new position in LeMaitre Vascular in the fourth quarter worth about $158,000. 84.64% of the stock is owned by institutional investors.

Remove Ads

Analysts Set New Price Targets

Several equities analysts have recently commented on LMAT shares. Wells Fargo & Company initiated coverage on LeMaitre Vascular in a report on Thursday, February 13th. They set an "equal weight" rating and a $95.00 target price for the company. Lake Street Capital increased their target price on LeMaitre Vascular from $105.00 to $110.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Oppenheimer cut LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. StockNews.com lowered shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a research report on Friday, December 13th. Finally, Barrington Research downgraded shares of LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Five analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $95.25.

LeMaitre Vascular Trading Down 0.7 %

LMAT traded down $0.56 on Wednesday, reaching $84.52. The company had a trading volume of 86,816 shares, compared to its average volume of 148,238. The company has a market capitalization of $1.91 billion, a P/E ratio of 46.19, a PEG ratio of 2.22 and a beta of 0.89. The company has a fifty day moving average of $93.94 and a 200-day moving average of $94.48. LeMaitre Vascular, Inc. has a one year low of $62.39 and a one year high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.49. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The business had revenue of $55.81 million during the quarter, compared to analysts' expectations of $55.99 million. Research analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

LeMaitre Vascular Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 27th. Stockholders of record on Thursday, March 13th will be issued a $0.20 dividend. This is a positive change from LeMaitre Vascular's previous quarterly dividend of $0.16. The ex-dividend date is Thursday, March 13th. This represents a $0.80 annualized dividend and a dividend yield of 0.95%. LeMaitre Vascular's dividend payout ratio is 41.24%.

Insider Activity

In other LeMaitre Vascular news, insider Trent G. Kamke sold 2,009 shares of the business's stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $82.12, for a total value of $164,979.08. Following the sale, the insider now directly owns 5,564 shares in the company, valued at approximately $456,915.68. The trade was a 26.53 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 10.79% of the company's stock.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.